Beijing Strong BiotechnologiesInc バランスシートの健全性
財務の健全性 基準チェック /56
Beijing Strong BiotechnologiesInc has a total shareholder equity of CN¥4.0B and total debt of CN¥1.2B, which brings its debt-to-equity ratio to 29.4%. Its total assets and total liabilities are CN¥5.5B and CN¥1.5B respectively. Beijing Strong BiotechnologiesInc's EBIT is CN¥639.4M making its interest coverage ratio 28.3. It has cash and short-term investments of CN¥994.6M.
主要情報
29.4%
負債資本比率
CN¥1.17b
負債
| インタレスト・カバレッジ・レシオ | 28.3x |
| 現金 | CN¥994.56m |
| エクイティ | CN¥3.96b |
| 負債合計 | CN¥1.49b |
| 総資産 | CN¥5.46b |
財務の健全性に関する最新情報
Recent updates
Is Beijing Strong BiotechnologiesInc (SZSE:300406) A Risky Investment?
Jul 25
Benign Growth For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Underpins Its Share Price
Jul 03An Intrinsic Calculation For Beijing Strong Biotechnologies,Inc. (SZSE:300406) Suggests It's 40% Undervalued
Jun 14Is Now The Time To Put Beijing Strong BiotechnologiesInc (SZSE:300406) On Your Watchlist?
Mar 21Improved Earnings Required Before Beijing Strong Biotechnologies,Inc. (SZSE:300406) Stock's 25% Jump Looks Justified
Mar 03Estimating The Fair Value Of Beijing Strong Biotechnologies,Inc. (SZSE:300406)
Feb 27財務状況分析
短期負債: 300406's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥287.6M).
長期負債: 300406's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥1.2B).
デット・ツー・エクイティの歴史と分析
負債レベル: 300406's net debt to equity ratio (4.3%) is considered satisfactory.
負債の削減: 300406's debt to equity ratio has increased from 0% to 29.4% over the past 5 years.
債務返済能力: 300406's debt is well covered by operating cash flow (53.3%).
インタレストカバレッジ: 300406's interest payments on its debt are well covered by EBIT (28.3x coverage).